MedTrace Logo

Immune Response followingTdap Vaccine in Pregnancy

NCT04082299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2025-05-09

No results posted yet for this study

Summary

Pregnancy involves changes in immune response. The investigators aim to evaluate the immune response to Tdap in pregnancy in comparison to non pregnant women usig proteomics and gene sequencing.

Conditions

  • Diphtheria-Tetanus-acellular Pertussis Vaccines

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Rinat Gabbay-Benziv, Dr · Hillel Yaffe Medical Center

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-12
Primary Completion
2023-10-19
Completion
2023-10-19

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082299 on ClinicalTrials.gov